# Champions Oncology, Inc. (CSBR)

> Champions Oncology, Inc. (CSBR) trades at $4.83 (-0.21%) as of 3:33:40 PM EST on Nov 10, 2026, -3.20% over the past month. Market cap is $67.37M, with 9.4 days to cover in short interest.

Canonical: https://massive.com/quote/csbr
Data as of: 2026-11-10T20:33:40.869Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$4.83** -0.01 (-0.21%)
As of 3:33:40 PM EST on Nov 10, 2026 · 15-minute delayed
Nasdaq · usd

## Stock performance

How Champions Oncology, Inc. (CSBR) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -0.93% |
| 1W | -0.72% |
| 1M | -3.20% |
| YTD | -30.61% |
| 1Y | -31.50% |
| 52-wk range | $4.59 – $8.31 |

From daily closes through Nov 10, 2026.

## Key statistics

Today's trading snapshot for CSBR: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $4.80 – $4.84 |
| Open | $4.82 |
| Prev close | $4.84 |
| Volume | 1.73K |
| Market cap | $67.37M |
| Shares out | 13.92M |

## Valuation and profitability ratios

Valuation and profitability ratios for Champions Oncology, Inc.: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | — |
| P/S | 1.11 |
| P/B | 17.30 |
| P/FCF | — |
| ROE | -28.4% |
| ROA | -3.3% |
| Debt/Equity | 0.00 |
| Div yield | 0.00% |

As of Nov 9, 2026

## Insider trading

[Champions Oncology, Inc. (CSBR) insider trading](https://massive.com/quote/csbr/insider-trading.md): open-market Form 4 buys and sells by Champions Oncology, Inc. insiders over the last 12 months.

## 8-K filings

Material corporate events Champions Oncology, Inc. has disclosed to the SEC on Form 8-K.

- Oct 16, 2026 · Annual meeting results
  “The proposal to approve the 2026 Equity Incentive plan, as described in the Company's 2026 proxy statement, was approved by the following votes.”
- Sep 10, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On September 10, 2026, Champions Oncology, Inc. (the "Company") issued a press release regarding the Company's unaudited financial results for its first quarter ended July 31, 2026.”
- Mar 30, 2026 · Director appointment
  “On March 24, 2026, the Board of Directors (the "Board") of Champions Oncology, Inc. (the "Company") appointed Dr. Brian Alexander as a director of the Company to fill the vacancy created by Dr. Breitfeld's resignation. Dr. Alexander, MD, MPH, serves as the Chief Executive Officer of Valo Health Inc., a company dedicated to utilizing artificial intelligence (AI) and advanced analytics to learn from patient experiences and accelerate the discovery and development of superior medicines at increased speed and scale, since November 2024.”
- Oct 16, 2025 · Annual meeting results
  “On October 16, 2025, Champions Oncology, Inc. (the "Company") held its Annual Meeting of Stockholders (the "Annual Meeting"). The following matters were submitted to a vote of the stockholders at the Annual Meeting and the voting results were as follows: 1. Election of Directors. The seven director nominees named in the Company's 2025 proxy statement were elected to serve for a one-year term expiring at the 2026 Annual Meeting of Stockholders or until their successors are duly elected and qualified, based upon the following votes: \[detailed voting results provided\]”
- Jul 21, 2025 · Executive compensation change
  “Pursuant to the agreement, he will receive an annual base salary of $500,000 and will have the opportunity to earn a discretionary target incentive bonus of 75% of his base salary. He will also receive multiple equity awards, including 225,000 options to purchase the Company's common stock, which will vest over a four-year period, and 475,000 options to purchase the Company's common stock which will vest at varying time points and are based on varying performance criteria.”

## Dividend history and stock splits

Champions Oncology, Inc.'s recent dividend payments and stock splits.

### Dividends

No recent dividends.

### Splits

- 1-for-12 · Aug 12, 2015

## CSBR short interest

How heavily CSBR is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 9.4 |
| Short interest | 77.65K |
| Avg volume | 8.27K |

As of Oct 15, 2026 · reported to FINRA twice monthly.

## CSBR news

The latest news and headlines about Champions Oncology, Inc. (CSBR).

- [Champions Oncology vs. Biodesix: Which Oncology Stock Is a Better Buy?](https://www.zacks.com/stock/news/3025711/champions-oncology-vs-biodesix-which-oncology-stock-is-a-better-buy?cid=CS-ZC-FT-microcap_article|investment_ideas-3025711) · Zacks Investment Research · Nov 6, 2026 · positive sentiment
- [CSBR Stock Slips Post Q1 Earnings Despite Revenue, Margin Growth](https://www.zacks.com/stock/news/2989999/csbr-stock-slips-post-q1-earnings-despite-revenue-margin-growth?cid=CS-ZC-FT-microcap_article|earnings-2989999) · Zacks Investment Research · Sep 15, 2026 · neutral sentiment
- [Champions Oncology (CSBR) Earnings Transcript](https://www.fool.com/earnings/call-transcripts/2026/03/13/champions-oncology-csbr-earnings-transcript/?source=iedfolrf0000001) · The Motley Fool · Mar 13, 2026 · neutral sentiment
- [Insiders Buying Solid Biosciences And 2 Other Stocks](https://www.benzinga.com/trading-ideas/long-ideas/24/01/36636408/insiders-buying-solid-biosciences-and-2-other-stocks) · Benzinga · Jan 16, 2024
- [Insiders Buying Tilly's And 2 Other Stocks](https://www.benzinga.com/trading-ideas/long-ideas/24/01/36572916/insiders-buying-tillys-and-2-other-stocks) · Benzinga · Jan 10, 2024

## About Champions Oncology, Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 214 |
| Listed | Oct 31, 1994 |

[Company website](https://www.championsoncology.com)

## FAQ

### What is the Champions Oncology, Inc. (CSBR) stock price today?

Champions Oncology, Inc. (CSBR) is trading at $4.83 (-0.21% on the day) as of 3:33:40 PM EST on Nov 10, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Champions Oncology, Inc.?

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services.

### What is the short interest in CSBR?

As of Oct 15, 2026, CSBR has 77.65K shares short and 9.4 days to cover.

### What exchange is CSBR listed on?

Champions Oncology, Inc. (CSBR) trades on Nasdaq in USD, in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry.

## Live data

Prices here are 15-minute delayed. For real-time CSBR quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=CSBR`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Champions Oncology, Inc. (CSBR) insider trading](https://massive.com/quote/csbr/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms